There’s an article in the New York Times about the problems faced by doctors in India who want to prescribe morphine to terminally ill patients, especially those who are suffering from cancer.
The centerpiece of the article is a Dr. Rajagopal, who runs a palliative care clinic in Kerala, the one Indian state where morphine tends to be accessible. Dr. Rajagopal has been lobbying to make morphine more accessible to ordinary Indians nationwide.
About 1.6 million Indians endure cancer pain each year. Because of tobacco and betel nut chewing, India leads the world in mouth and head tumors, and has high rates of lung, breast and cervical cancer. Tens of thousands also die in pain from AIDS, burns or accidents.
But only a tiny fraction — Dr. Rajagopal estimates 0.4 percent — get relief.
Clinics dispensing morphine are so scarce that some patients live 500 miles from the nearest. Calcutta, a city of 14 million, has only one. (link)
Ironically, India grows the poppies from which much of the morphine used in western countries is derived. But government regulations (a highly familiar villain, in the Indian context) make it virtually impossible for ordinary people who are seriously ill to get access to it: Continue reading






